MACQUARIE GROUP LTDMACQUARIE GROUP LTD

Institutional investor · Portfolio as of Q1 2020

Top Holdings1,966 positions

Checking export access…
Activity:

Merck & Co., Inc

11.8M$911.1M1.9%$62.63-4.24%
6 qtrssince 2018-Q4
Decreased
0

CONAGRA BRANDS INC

29.2M$855.4M1.8%$20.63+5.28%
6 qtrssince 2018-Q4
Decreased
0

PFIZER INC

24.9M$814.3M1.7%$28.53-21.50%
6 qtrssince 2018-Q4
Decreased
0

MONDELEZ INTL INC

14.9M$748.4M1.5%$41.11+2.95%
6 qtrssince 2018-Q4
Decreased
0

Johnson & Johnson

5.7M$745.9M1.5%$112.16-2.19%
6 qtrssince 2018-Q4
Decreased
0

CIGNA CORP NEW

4.2M$739.6M1.5%$150.13+6.17%
6 qtrssince 2018-Q4
Decreased
0

CVS HEALTH CORP

11.8M$698.9M1.4%$45.01+6.88%
6 qtrssince 2018-Q4
Decreased
0

The Allstate Corporation

7.6M$692.6M1.4%$82.60-4.41%
6 qtrssince 2018-Q4
Decreased
0

VERIZON COMMUNICATIONS INC

12.8M$689.2M1.4%$37.25-2.98%
6 qtrssince 2018-Q4
Decreased
0

INTEL CORP

12.6M$683M1.4%$41.50+15.61%
6 qtrssince 2018-Q4
Decreased
0

Abbott Laboratories

8.6M$675.3M1.4%$70.62-0.91%
6 qtrssince 2018-Q4
Decreased
0

Oracle Corp.

13.8M$668.4M1.4%$47.62-7.45%
6 qtrssince 2018-Q4
Decreased
0

ARCHER DANIELS MIDLAND CO

19M$667.7M1.4%$33.44-12.59%
6 qtrssince 2018-Q4
Decreased
0

Cisco Systems, Inc.

17M$667.3M1.4%$40.67-19.94%
6 qtrssince 2018-Q4
Decreased
0

Broadcom Inc

2.8M$661M1.4%$24.69-16.43%
6 qtrssince 2018-Q4
Decreased
0

CARDINAL HEALTH INC

13.7M$657.9M1.4%$38.79+5.91%
6 qtrssince 2018-Q4
Decreased
0

Northrop Grumman Corporation

2.2M$652.2M1.3%$267.54+1.55%
6 qtrssince 2018-Q4
Decreased
0

EDISON INTL

11.6M$635.3M1.3%$46.24-13.10%
6 qtrssince 2018-Q4
Decreased
0

AT&T INC

21.6M$629M1.3%$14.67-4.56%
6 qtrssince 2018-Q4
Decreased
0

COMCAST CORP NEW

18.2M$626.5M1.3%$26.80-1.82%
6 qtrssince 2018-Q4
Increased
80
$48.7B
AUM
1,966
Positions
Q1 2020
Filing
HI score · 1.5/5
Quarterly 13F Value Change
+13%Q1'19$58.6B+200%Q2'19$176B-66%Q3'19$59.7B+17%Q4'19$70B-30%Q1'20$48.7B
Activity profile
$ moved · Q1'20
New1%Increased35%Decreased59%Exited6%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.0 years
<1Q7%1-4Q16%1-2Y77%2Y+0%

MACQUARIE GROUP LTD manages $48.7B across 1966 positions as of Q1 2020. Top holdings: MRK (1.9%), CAG (1.8%), PFE (1.7%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 1.5/5.0.

Q1 2020 Summary

Active quarter - 166 new positions, 122 exits, 633 increased. Top move: CMCSA (INCREASED, conviction 80). Portfolio: $48.7B across 1966 positions.

Top holdings by portfolio weight

Total AUM$49B
MRK1.87%
CAG1.76%
PFE1.67%
MDLZ1.54%
JNJ1.53%
CI1.52%
CVS1.44%
ALL1.42%
VZ1.42%
INTC1.40%
Other1.39%

Portfolio allocation by GICS sector

Sectors11
Healthcare17.73%
Financial Services13.89%
Technology13.71%
Unknown9.50%
Consumer Defensive9.11%
Communication Services8.57%
Industrials7.24%
Consumer Cyclical6.71%
Real Estate4.62%
Utilities3.78%
Other5.13%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Financial Services, Technology
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Below Average(1.5 / 5.0)
Holdings P&L54
Conviction40
Concentration52
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
CTRECTRECARETRUST REIT INC
Q4 2024 → Q2 2026+98,815 shares+$5.5M
7Q
IVZIVZINVESCO LTD
Q4 2024 → Q2 2026+2.4M shares+$75.4M
6Q
GLPIGLPIGAMING & LEISURE PPTYS INC
Q1 2025 → Q2 2026+36,515 shares+$490,278
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used